NovoCure Ltd — Director's Dealing 2020

Sep 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-09-18

Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-18	Ordinary Shares	M	8262	$7.48	Acquired	150869	Direct
2020-09-18	Ordinary Shares	S	200	$106.915	Disposed	150669	Direct
2020-09-18	Ordinary Shares	S	2513	$108.494	Disposed	148156	Direct
2020-09-18	Ordinary Shares	S	3536	$109.226	Disposed	144620	Direct
2020-09-18	Ordinary Shares	S	1813	$110.24	Disposed	142807	Direct
2020-09-18	Ordinary Shares	S	200	$110.885	Disposed	142607	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-18	Options to Buy Ordinary Shares	$7.48	M	8262	Disposed	2024-02-25	Ordinary Shares (8262.0)	Direct

Footnotes

F1: On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 200 shares in multiple trades at prices ranging from $106.74 to $107.09. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 2,513 shares in multiple trades at prices ranging from $107.84 to $108.83. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 3,536 shares in multiple trades at prices ranging from $108.84 to $109.82. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 1,813 shares in multiple trades at prices ranging from $109.84 to $110.66. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F5: On September 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen, Mr. Groenhuysen sold 200 shares in multiple trades at prices ranging from $110.85 to $110.92. The price reported above reflects the weighted average sale price. Mr. Groenhuysen hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F6: Fully vested as of the date hereof.